← Evidence map

ArticleCost effectiveness and resource allocation : C/E2026

Influence of clinical benefit and cost-effectiveness on reimbursement decisions for lung cancer drugs in Spain.

Pelayo Nieto-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42174601